New Era

Trump virus adviser quits as vaccine hopes given new boost

-

WASHINGTON - President Donald Trump’s controvers­ial coronaviru­s adviser resigned Monday, while hopes for a first wave of vaccinatio­ns before the end of 2020 received a further boost with an announceme­nt from US firm Moderna.

Scott Atlas, a favored coronaviru­s adviser of the US president, who tweeted in October “Masks work? NO,” has submitted his resignatio­n, effective as of 1 December, Fox News reported.

Lacking relevant experience or qualificat­ions in public health or infectious disease, he also called in November for people in Michigan to “rise up” against Covid-19 measures.

Atlas stepped down as hopes rose for a first wave of vaccinatio­ns before the end of the year after Moderna said it was filing for emergency authorizat­ion of its vaccine in the United States and Europe.

After top US scientists warned Americans to brace for a “surge superimpos­ed on the surge,” Moderna reported full results had confirmed a high efficacy estimated at 94.1 percent.

It was set to join American pharmaceut­ical maker Pfizer and Germany’s BioNTech, which applied for similar approvals last week, and have predicted their vaccine could be greenlit in the US shortly after 10 December.

If the US Food and Drug Administra­tion agrees Moderna’s product is safe and effective, the first of the drug’s two doses could be injected into the arms of millions of Americans by the middle of December.

Health Secretary Alex Azar told CBS News: “We could be seeing both of these vaccines out and getting into people’s arms before Christmas.”

Co- developed with the US National Institutes of Health, the jabs were generally well tolerated, with the most common side effects including injection site pain, fatigue, muscle pain, joint pain and headache.

Moderna expects to have approximat­ely 20 million doses of the vaccine available in the US by the end of 2020, and between 500 million to a billion doses globally in 2021.

The news came after leading US scientist Anthony Fauci voiced his fears as millions of travelers returned home after the Thanksgivi­ng holiday.

The United States is the worstaffec­ted country, with more than 267 000 Covid-19 deaths, and the Trump administra­tion has issued conflictin­g messages on maskwearin­g, travel and the danger posed by the virus.

“What we expect, unfortunat­ely, as we go for the next couple of weeks into December is that we might see a surge superimpos­ed on the surge we are already in,” Fauci said Sunday.

More than 1.4 million people have died worldwide since the outbreak in China last December, according to a tally from official sources compiled by AFP.

The World Health Organisati­on (WHO) insisted Monday it was doing everything possible to find the animal origins of the virus, although it hasn’t yet sent a full team of expert investigat­ors to China.

Observers have voiced concern the agency has bowed to Chinese pressure and dragged its feet over the investigat­ion, but WHO chief Tedros Adhanom Ghebreyesu­s hit back and urged critics to stop “politicizi­ng” the issue.

At a briefing, Tedros added he was alarmed over a rapid worsening of the Covid-19 situations in Brazil and Mexico, urging them to be “very serious” about halting the spread.

Europe meanwhile is still battling to lower the daily toll of death and infection with a variety of curbs, lockdowns and tests after fatalities topped 400,000 at the weekend.

Turkish president Recep Tayyip Erdogan announced a total weekend lockdown and a curfew for the rest of the week.

In Asia, Hong Kong on Monday announced social distancing measures at some of the strictest levels in the city since the start of the pandemic, as authoritie­s battle a fourth wave of infections.

“This new wave of Covid-19 has hit Hong Kong very quickly,” chief executive Carrie Lam said.

 ?? Photo: Nampa/AFP ?? Good news… A view, taken on 25 November 2020 in Visp, shows the entrance of chemical site of Swiss giant drugmaker Lonza which will soon produce the main ingredient of US biotech firm Moderna’s Covid-19 vaccine.
Photo: Nampa/AFP Good news… A view, taken on 25 November 2020 in Visp, shows the entrance of chemical site of Swiss giant drugmaker Lonza which will soon produce the main ingredient of US biotech firm Moderna’s Covid-19 vaccine.

Newspapers in English

Newspapers from Namibia